In recent years, cancer immunotherapy has undergone a transformative shift toward
personalized and targeted therapeutic strategies. Bacteria‐derived outer membrane …

Tumor vaccines, an important part of immunotherapy, prevent cancer or kill existing tumor
cells by activating or restoring the body's own immune system. Currently, various …

The biosafety concerns associated with fecal microbiota transplant (FMT) limit their clinical
application in treating ulcerative colitis (UC). Gut microbiota secrete abundant extracellular …

Colorectal cancer (CRC) is a major global health concern, and the development of effective
treatment strategies is crucial. Enzyme prodrug therapy (EPT) shows promise in combating …

Recent discoveries in commensal microbiota demonstrate the great promise of intratumoral
bacteria as attractive molecular targets of tumors in improving cancer treatment. However …

Bacterial‐derived micro‐/nanomedicine has garnered considerable attention in anticancer
therapy, owing to the unique natural features of bacteria, including specific targeting ability …

Lactic acid bacteria derived extracellular vesicles (LAB-EVs) are nano-sized and carry a
variety of biological cargoes. LAB-EVs have proven to be potential mediators of intercellular …

The efficacy and safety of mRNA vaccines both rely on a fine-tuning of specific humoral and
cellular immune responses. Instead of adjustments in vaccine component, we proposed a …

Research on nano-armored bacterial materials (NABM) has attracted considerable attention
because of their ability to exert synergistic effects on bacteria and nanomaterials through …

Bacterial infection and an excessive inflammatory response are two major factors that affect
the healing of infected wounds. The zinc oxide/copper sulfide (ZnO‐CuS) microspheres …